Search

You searched for "student"

1569 results found

My top five: Uses of artificial intelligence in ophthalmology

3 August 2023 | | EYE - General
Artificial Intelligence (AI) has emerged as a prominent topic of discussion within the field of ophthalmology, captivating researchers and practitioners alike. Although recent attention has been drawn to the integration of AI in ophthalmology, it’s important to recognise that AI...

My Top Five: Uses of artificial intelligence in ophthalmology

3 August 2023 | | EYE - General
Artificial Intelligence (AI) has emerged as a prominent topic of discussion within the field of ophthalmology, captivating researchers and practitioners alike. Although recent attention has been drawn to the integration of AI in ophthalmology, it’s important to recognise that AI...

Report: UKEGS 2024

29 October 2024 | UKEGS, 2024, conferences, meetings, events, industry, glaucoma, Glaucoma UK, Nishani Amerasinghe, Andrew Tatham
It was an incredible experience heading down to UKEGS 2024 earlier this month in Southampton. The entire Glaucoma UK team, along with the UKEGS overseeing panel Nishani Amerasinghe, Andrew Tatham, Professir Anthony King and Professor Gus Gazzard, took great care...

Pigmented paravenous retinochoroidal atrophy

4 December 2024 | | EYE - Imaging, EYE - Vitreo-Retinal
Presentation A 46-year-old Caucasian female was referred to the eye clinic by her local optician following a routine sight test. She was noted to have pigmentary retinal changes in both eyes but was asymptomatic with no visual complaints. At presentation...

Increasing access to eye care through community outreach clinics in Uganda

1 June 2019 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - Glaucoma, EYE - General
There has been a VISION 2020 LINK between Mulago Hospital and Makerere University in Kampala, Uganda and the Royal Free Hospital, London, since 2010. There have been regular training visits between teams from the eye departments at Mulago and the...

Ophthalmology in a War Zone: an interview with Dr Volodymyr Melnyk

7 December 2022 | | EYE - General, EYE - Cornea, EYE - Cataract, EYE - Glaucoma
It is now nine months since the full-scale Russian invasion of Ukraine commenced in late February 2022, with Putin announcing a “special military operation” to “denazify and demilitarise” Ukraine. The rest of the world, however, saw it for what it...

Two cases of acute syphilitic posterior placoid chorioretinitis

4 December 2025 | | EYE - Imaging, EYE - Vitreo-Retinal
Syphilis has re-emerged as a significant public health concern, with the World Health Organization (WHO) estimating that 8 million adults aged 15–49 acquired syphilis in 2022. Untreated syphilis can have severe consequences, including cardiovascular, neurological and ocular complications. Ocular manifestations...

New IGA research award

11 February 2020
Applications open for new £50,000 glaucoma research Allied Healthcare professionals award The International Glaucoma Association (IGA) announces call for applications for new £50,000 Allied Healthcare professionals award for glaucoma research. The new award, which opened on 21 October 2019 and...

CHEC and Royal National Institute for Blind People Launch Strategic Partnership

31 March 2022
CHEC has today announced the launch of a new partnership with the Royal National Institute of Blind People.

UK ophthalmologists discuss value of ultra-widefield multimodality retinal imaging

7 June 2023 | optomap, ophthalmology, ultra-widefield
Utilising optomap ultra-widefield (UWF™) multimodality retinal imaging with integrated SS (or SD) OCT in clinical practice contributes to identifying unexpected pathologies in a patient without visual complaints, report 81% of clinicians at industry webinar.

Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines

8 December 2023 | NuVision, Andy Hill, amniotic membranes, guidelines, AOP, optometrist, outpatient, dry eye, lens
There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.

Orbis named winner of 2023 Amazon Web Services IMAGINE grant for non-profits

11 January 2024 | charity, international, funding, AI, Asia, Africa
Orbis will work with Amazon's cloud computing arm to expand access to artificial intelligence-assisted eye screenings in Asia and Africa.